ELTROMBOPAG for Hepatitis c: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where ELTROMBOPAG was used for Hepatitis c.
Most Reported Side Effects for ELTROMBOPAG
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Platelet count decreased | 968 | 17.7% | 148 | 545 |
| Death | 629 | 11.5% | 629 | 80 |
| Drug ineffective | 554 | 10.1% | 86 | 201 |
| Product use in unapproved indication | 303 | 5.5% | 70 | 69 |
| Thrombocytopenia | 262 | 4.8% | 33 | 112 |
| Off label use | 255 | 4.7% | 50 | 87 |
| Headache | 229 | 4.2% | 27 | 125 |
| Pyrexia | 229 | 4.2% | 45 | 163 |
| Haemoglobin decreased | 213 | 3.9% | 41 | 117 |
| Pneumonia | 204 | 3.7% | 86 | 124 |
| Platelet count increased | 186 | 3.4% | 24 | 101 |
| Haemorrhage | 173 | 3.2% | 35 | 80 |
| Therapy non-responder | 166 | 3.0% | 39 | 42 |
| Malaise | 154 | 2.8% | 31 | 116 |
| Anaemia | 146 | 2.7% | 28 | 53 |
Other Indications for ELTROMBOPAG
Immune thrombocytopenic purpura (1,734)
Aplastic anaemia (1,121)
Immune thrombocytopenia (792)
Product used for unknown indication (612)
Thrombocytopenia (531)
Myelodysplastic syndrome (246)
Thrombocytopenic purpura (117)
Platelet count decreased (57)
Bone marrow failure (52)
Acute myeloid leukaemia (40)
Other Drugs Used for Hepatitis c
RIBAVIRIN (20,657)
PEGINTERFERON ALFA-2A (10,970)
LEDIPASVIR\SOFOSBUVIR (8,924)
DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264)
SOFOSBUVIR (7,691)
SOFOSBUVIR\VELPATASVIR (4,956)
GLECAPREVIR\PIBRENTASVIR (4,016)
OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906)
TELAPREVIR (2,604)
DASABUVIR (2,603)